+44 (0)1865-842-976 (UK)

+91 20 30108 270 (ASIA)

Genome editing holds great promise of breakthroughs in areas of pharmaceutical science, ever since the discovery of the CRISPR/Cas systems. 

This conference will bring together key industry leaders and researchers look at the various concepts, challenges and applications of genome editing tools like CRISPR/Cas9 and TALENs.

Case studies and sessions will delve into the potential applications of genome editing tools from modern biomedical and therapeutic applications. Special emphasis will be given on CRISPR system looking at the concept, technology and various challenges like integration of genome, off-target effects and delivery systems.

With the tremendous response on our past annual Genome Editing & Engineering Conference 18th- 19th February 2016, we are excited to introduce the 2nd Annual Genome Editing & Engineering Conference (6th - 7th February 2017 in San Diego).

Post Show Report 2016

Click here to view post show report of Genome Editing & Engineering Conference 2016.

This event is co-located with our 2nd Annual Biomarker Conference &

 2nd Annual NGS Data Analysis and Informatics Conference.

Key Highlights

  • RNA guided nuclease for genome modifications
  • Different gene delivery systems
  • CRISPR as a molecular tool for programmable gene expression and gene therapy
  • Human gene therapy using Zebrafish model
  • Gene knock in and genomic screening using TALEN and CRISPR
  • CRISPR biomedical research applications
  • RNAi based screening technologies
  • Genome editing for disease modeling
  • NgAgo as the latest tool for genome editing

conference Registration Form



Academic Delegate$399
Industry Delegate $499
Solution Provider Delegate$999


Key Highlights

  • RNA guided nuclease for genome modifications
  • Different gene delivery systems
  • CRISPR as a molecular tool for programmable gene expression and gene therapy
  • Human gene therapy using Zebrafish model
  • Gene knock in and genomic screening using TALEN and CRISPR
  • CRISPR biomedical research applications
  • RNAi based screening technologies
  • Genome editing for disease modeling
  • NgAgo as the latest tool for genome editing

Who Should Attend ?

From Pharmaceutical and Bio-pharmaceutical companies:

Chief Scientific Officer/ Directors/ Heads/ VP/ Senior Scientists/ Principal Scientist/ Project Leader in:

  • Genome biology
  • Functional genomics
  • Gene/Cell therapy
  • Genome/Genetic Engineering
  • Genetics
  • Molecular Biology
  • Drug discovery
  • Therapeutics
  • Regenerative medicines
  • Translational sciences
  • Immunology
  • Immuno-oncology


    From Universities and Research institutes:

    Professors/ Assistant Professors/ Researchers/ Scientists/ Principal Scientists in:

  • Genomic/Genetic Engineering
  • Genetics
  • Functional Genomics
  • Genome Biology
  • Gene Editing/ Genome Editing
  • Molecular Biology
  • Bio-molecular Engineering
  • Bio-chemistry
  • Regenerative medicines
  • Stem cell
  • Gene Therapy/Cell Therapy
  • Immunology
  • Immunotherapy


Advisory Panel

  • Dr. Jacques P Tremblay
    Full Professor, Department of Molecular Medicine
    University of Laval

  • Dr. C.B. Gurumurthy
    Director, Trangenic Core Facility,
    Univeresity of Nebraska Medical Center


  • Dr. Jacques P Tremblay

    Full Professor, Department of Molecular Medicine, University of Laval
  • Dr. C.B. Gurumurthy

    Director, Trangenic Core Facility, Univeresity of Nebraska Medical Center
  • Dr. Niren Murthy

    Professor of Bioengineering, University of California at Berkeley
  • Dr. Ite A. Laird-Offringa

    Director, Programs in Biomedical and Biological Sciences, University of Southern California
  • Dr. Deepak Rajpal

    Director, Computational Biology, GlaxoSmithKline
  • Dr. Dana Carroll

    Distinguished Professor, Department of Biochemistry, University of Utah School of Medicine
  • Dr. Raman Sood

    Head, Zebrafish Core, National Human Genome Research Institute, National Institutes of Health
  • Dr. Wu Haoquan

    Associate Professor, Infectious Diseases, University of Texas
  • Dr. Tetsushi Sakuma

    Assistant Professor, Molecular Genetics laboratory, Hiroshima University
  • Dr. Theodore Friedmann

    Professor, Institute of Engineering in Medicine, University of California, San Diego
  • Dr. Ron Weiss

    Professor of Biological Engineering, Massachusetts Institute of Technology
  • Dr. Imran Noorani

    Sanger Institute
  • Dr. Daniel Anderson

    Associate Professor, Department of Chemical Engineering, Massachusetts Institute of Technology
  • Dr. Nicholas J. Schork

    Director Human Biology, J. Craig Venter Institute (JCVI)
  • Dr. Michael Kyba

    Professor, Department of Pediatrics, University of Minnesota
  • Dr. Mark Dewitt

    Research Fellow, Innovative Genomics Initiative, Berkley, CA
  • Dr. Cecilia Cotta-Ramusino

    Senior Scientist, Editas Medicine
  • Benjamin Borgo

    Product Manager , Agilent Technologies, CA
  • Dr. David Shedlock

    Director-Immunooncology, Poseida Therapeutics, CA
  • David Nelles

    CTO & Co-founder, Locana Inc.
  • Dr. Amy L. Firth

    Assistant Professor of Medicine, University of South California
  • Mark Behlke

    Chief Scientific Officer, Integrated DNA Technologies, Iowa
  • Ryan Cawood

    Chief Executive Officer, Oxford Genetics, United Kingdom
  • Caroline Beckett

    Global CRISPR Product Manager, MilliporeSigma, Missouri
  • Annaleen Vermeulen

    Senior Scientist II, Dharmacon, GE Healthcare, Colorado


Gold Sponsor

Agilent TechnologiesAgilent Technologies

Agilent’s Genomics group is committed to providing an innovative suite of products for genetic analysis. Our market-leading CGH microarrays, NGS target enrichment, mutagenesis, and Bioanalyzer & TapeStation products complement an entire portfolio of solutions, including PCR and qPCR instruments and reagents, gene expression microarrays, as well as design and analysis software.


MilliporeSigma is the preeminent life science company, supplying Sigma-Aldrich brand gene editing products and services. With over 300,000 products, including CRISPR reagents, whole genome screening libraries (including Sanger arrayed and GeCKO pooled libraries), validation services and technical expertise, MilliporeSigma has committed to solving the toughest problems in life science. 



Cyagen Biosciences
Cyagen Biosciences
 is the world's largest provider of custom transgenic and knockout mouse services. A leader in molecular biology tools and research-use stem cells and related culture reagents, Cyagen offers premium customer service; price-matching, complimentary technical consultations, full confidentiality and a 100% money-back guarantee. Cyagen offers BAC and PiggyBac transgenics, CRISPR-mediated genome editing and Turboknockout® - an ES cell mediated service that generates conditional knockout, reporter knockin and humanization mouse models in only 6-8 months.


Synthego is a leading provider of genome engineering solutions. Our flagship product, CRISPRevolution, is a portfolio of syntheticguide RNA designed for CRISPR genome editing and research. Synthego’s vision is to bring precision and automation to genome engineering, enabling rapid and cost-effective research with consistent results for every scientist.


Benchling is a modern informatics platform that powers complex life science R&D workflows. It integrates an electronic lab notebook with registration, LIMS and molecular biology tools and allows teams to automate registration, track samples, query results and collaborate. Benchling is used by over 45,000 scientists in industry and academia worldwide.

Twist Bioscience

Twist Bioscience

At Twist Bioscience, our expertise is accelerating science and innovation by leveraging the power of scale. We have developed a proprietary semiconductor-based synthetic DNA manufacturing process featuring a 10,000-well silicon platform capable of producing synthetic biology tools, including genes, oligonucleotide pools and variant libraries. By synthesizing DNA on silicon instead of on traditional 96-well plastic plates, our platform overcomes the current inefficiencies of synthetic DNA production, and enables cost-effective, rapid, high-quality and high throughput synthetic gene production, which in turn, expedites the design, build, test cycle to enable personalized medicines, pharmaceuticals, sustainable chemical production, improved agriculture production, diagnostics, biodetection and data storage.

Oxford GeneticsOxford Genetics

Oxford Genetics Ltd, a leader in synthetic biology, is a specialised contract research organisation offering services to support the discovery, development and production of biologics, gene and cell therapies. A unifying theme across the portfolio is expertise in designing DNA, optimising expression of proteins, cell line development, and improving viral delivery systems.

GE DharmaconGE Dharmacon
As a leader in custom RNA synthesis, Dharmacon part of GE Healthcare was an early participant in the newly discovered field of RNA interference, and contributed several key scientific findings. This leadership has continued through technical advances in bioinformatics, and chemical modifications to improve performance. The company’s areas of research and research tools have expanded to support all aspects of RNAi interference; siRNA, lentiviral shRNA, tools for microRNA research, and whole-genome scale libraries for RNAi functional screens of genes, microRNAs, and long non-coding RNAs. Dharmacon has the largest collection of cDNAs and ORFs commercially available, and a unique set of CRISPR-Cas9 gene editing tools.

Desktop GeneticsDesktop Genetics

Desktop Genetics is a bioinformatics company building a machine learning platform for personalized genome editing. We work with scientists around the world to design and validate CRISPR experiments for research and therapeutic applications.

Integrated DNA Technologies

Integrated DNA Technologies (IDT) 

Integrated DNA Technologies
is the world leader in delivering custom nucleic acid products for the life sciences market in the areas of academic research, medical diagnostics, biotechnology, agriculture, and pharmaceutical development. IDT has developed proprietary technologies for genomics applications such as next generation sequencing, CRISPR genome editing, qPCR, and RNA interference. Through its GMP services, IDT manufactures products used in diagnostic tests for cancer and inherited and infectious diseases.

For sponsorship opportunities please contact Ajay Nimbalkar at 



All Poster presentations will take place in breaks and alongside the breakout sessions of the congress.  All the presentation will be displayed in a dedicated area along with accepted posters from both industry & Academia.

To present a poster the presenter should be registered as a delegate and the poster space will be assigned on a first come first basic (Subjected to successful registration & space availability)In order to present a poster at the forum you need to be registered as a delegate.

Please note that there is limited space available and posters space is assigned on a first come first served basis (subject to checks and successful registration).

Posters should be presented as A0 or US equivalent, size E (841mm x 1189mm or 34 x 44 inches respectively) in portrait orientation.

Poster presentations are available to registered delegates only.

For further details and requirements please contact:

Ajay Nimbalkar
Email: ajay.nimbalkar@mnmconferences.com
Tel:+91 20 6708 0299

Posters Submission Form



California LifeSciencesCalifornia Life Sciences Association (CLSA)
California Life Sciences Association (CLSA) is the leading voice for California’s life sciences sector. We work closely with industry, government, academia and other stakeholders to shape public policy, drive business solutions and grow California’s life sciences innovation ecosystem. CLSA serves over 750 biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors and service providers. CLSA was founded in 2015 when the Bay Area Bioscience Association (BayBio) and the California Healthcare Institute (CHI) merged to create the state’s most influential life sciences advocacy and business leadership organization.

AZBioAZBio (Arizona Bioindustry Association)
AZBio (Arizona Bioindustry Association) is committed to making LIFE better for people and to supporting the collaborative efforts of  its members in growing Arizona’s bioscience industry. Over 1,400 life science companies call Arizona “home” including: Arizona Alzheimer’s Consortium, Arizona State University (home of the Biodesign institute and the National Biomarker Development Alliance), Barrow Neurological Institute at St. Joseph’s Hospital (Dignity Health), Banner MD Anderson, Banner Health Research Institutes, Cancer Treatment Centers of America, Mayo Clinic, Translational Genomic Research Institute (TGen), Virginia G. Piper Cancer Center(HonorHealth), and The University of Arizona.  Learn more at www.AZBio.org


BioUtah is an independent, non-profit 501(c)(6) trade association serving Utah's life science industry. Our primary members include organizations focused on research and development, manufacturing and commercialization or provide supportive services to life science technologies and treatments.

Utah’s life science industry consists of a diverse spectrum with strengths in medical device manufacturing and services, research and testing, biotechnology, pharmaceuticals and healthcare IT amongst others; and is a key driver of Utah’s economy.

Northwest Association for Biomedical Research
Northwest Association for Biomedical Research (NWABR)
Northwest Association for Biomedical Research (NWABR) was founded in 1989 with a mission to promote the understanding of biomedical research and its ethical conduct.  NWABR is an independen
t membership based 501(c) 3 association representing the biomedical research community.  NWABR’s members represent leaders in the biomedical and biotechnology industry, universities and non-profit organizations.  We work with and for our members to strengthen public trust in research through education and dialogue. 
As a membership based organization NWABR encourages personal interactions between scientists, the public, students, and teachers, helping to demystify the scientific process.  As a connector between the academic and scientific communities and the public, NWABR accomplishes its mission by providing opportunities to engage people through various channels of communication, such as social media, electronic newsletters, events, networking sessions, student and teacher education programs, and by continuing best practices education for the biomedical research community.

Colorado BSAColorado BioScience Association
Colorado BioScience Association champions life science. The not-for-profit organization represents more than 350 member organizations and serves as the hub of Colorado’s thriving bioscience sector by connecting innovators to funding, infrastructure, research and talent. CBSA grows the bioscience workforce and leads business expansion policies to advance the industry in our state.

DNA Digest

DNAdigest is a non-profit organisation founded in 2013 in Cambridge, UK. The objectives of DNAdigest are to educate, facilitate, and engage on issues regarding access to genomic data for research. DNAdigest organises symposia, hackdays, issues a newsletter and publishes a blog (dnadigest.org/news)
DNAdigest is a community of individuals from diverse backgrounds who all want to see data used to its full potential for the benefit of patients. DNAdigest is part of the Global Alliance for Genomics and Health (https://genomicsandhealth.org)

Georgio BioGeorgia Bio
Georgia Bio (www.gabio.org) is the private, non-profit association whose members include pharmaceutical, biotechnology and medical device companies, medical centers, universities and research institutes, government groups and other business organizations involved in the development of life sciences related products and services.

RegMedNet is a free online information and networking hub covering all aspects of the multidisciplinary field of regenerative medicine. By allowing members to quickly access user-generated news, discussion and opinion from the fast-moving and diverse field, share their own content and insights, and access key journal articles, RegMedNet enables the knowledge sharing, connection and collaboration that will help this exciting field progress further and bring benefits to patients faster.

Maine Bioscience
The Bioscience Association of Maine (BAM)
The Bioscience Association of Maine (BAM) is a trade organization which promotes the industry's steady growth, interprets its benefits to the public, and influences pertinent public policy.
 As the association for Maine’s life sciences community, BAM promotes cooperation between Maine’s bioscience-related businesses, supports the biotech industry in the state and beyond, develops business-to-business opportunities, and serves as a united industry voice to promote a science-friendly environment.

Social Media Partner 

Welcome! You are viewing the First LinkedIn-CRISPR Networking Group. Linkedin CRISPRs (Clustered Regularly Interspaced Short Palindromic Repeats) multiple short direct repeats that are found in the genomes of approximately 40% of bacteria. CRISPR functions as a prokaryotic immune system, in that it confers resistance to exogenous genetic elements. The CRISPR system provides a form of immunity. Short segments of foreign DNA, called spacers, are incorporated into the genome between CRISPR repeats, and serve as a 'memory' of past exposures. CRISPR spacers are then used to recognise and silence exogenous genetic elements in a manner analogous to RNAi in eukaryotic organisms. CRISPRs have thus huge potential to commandeer the down-regulation, expression and importantly, the KD of eukaryotic genes.



The 2nd Annual Genome Editing and Engineering Conference will be held at the San Diego Marriott La Jolla in USA.

San Diego Marriott La Jolla

4240 La Jolla Village Drive,
La Jolla, California - 92037

Hotel Booking Link

Our block of rooms at the congress rate has now been filled.  You can see a list of nearby hotels by clicking here.  (Please note that we do not authorise any 3rd party agencies (e.g. Exhibitors Housing Management) to book on our behalf and, occasionally, companies fraudulently try to represent us.  If you are contacted by anyone other than me regarding your accommodation requirements for this event, please let us know immediately)

About the Hotel

Effortlessly stylish and filled with exceptional amenities, the San Diego Marriott La Jolla offers the perfect home base for your visit to the Golden Triangle. Hotel's central location provides hassle-free access to many of downtown La Jolla's most popular attractions, as well as to the University of California at San Diego. Pet-friendly rooms and suites include deluxe pillowtop beds, marble bathrooms and high-speed Wi-Fi; many also feature private balconies.

For further Information please contact:
Email: events@marketsandmarkets.com